翌圣生物 Yeasen｜生命科学试剂与诊断原料一站式平台

Abstract

Hepatic ischemia-reperfusion injury (IRI) is a major cause of liver dysfunction and failure following surgical procedures such as liver resection and transplantation. Although numerous studies have reported various underlying mechanisms involving both parenchymal and nonparenchymal cells, there is an urgent need to develop human-relevant models that faithfully recapitulate clinical IRI. To address this, we established a novel three-dimensional liver organoid model using NAC linker technology to simulate hepatic IRI in both murine and human contexts. By coculturing primary hepatocytes with nonparenchymal cells (NPCs) and immune components such as peripheral blood mononuclear cells (PBMCs) or THP-1 monocytes, we developed multicellular organoids that recapitulate key structural and functional features of the liver. We demonstrated that oxidative stress induced by H 2 O 2 triggers inflammatory and apoptotic responses consistent with IRI, which are exacerbated by immune cell involvement. Furthermore, we identified the YAP signaling pathway as a critical protective mechanism: its activation attenuated cellular damage and inflammation, whereas its inhibition worsened injury. These findings highlight the utility of NAC-liver organoids as a robust platform for studying IRI mechanisms and screening therapeutic agents, with YAP agonists emerging as promising candidates for mitigating IRI-related damage.